Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.KCI’s VAC system found effective in diabetic foot ulcers
The study has involved 342 patients with complex, hard-to-heal diabetic foot ulcers with 90% of therapy days occurring in the home care setting. In the study, for patients
The study has involved 342 patients with complex, hard-to-heal diabetic foot ulcers with 90% of therapy days occurring in the home care setting. In the study, for patients
Judd Hoffman, president and CEO of AMT, said: “Using AMT’s proven global sales experience and extensive global distributor network as our foundation, we intend to increase SheerVision’s Firefly
Vertex intends to grant the underwriters an over-allotment option to purchase up to an additional 900,000 shares of its common stock. Concurrently with the offering of its common
This transaction, including a new four-year supply agreement with DePuy, enhances Greatbatch’s and Precimed’s strategic relationship with one of the largest orthopedic companies in the world. The addition
This decision comes after its recent acquisition of Intertech Bio which has propelled the company into the multi-billion dollar biotechnology industry through the addition of significant partnerships and
Under the terms of the agreement, Sigma-Tau will oversee all necessary regulatory filings, and will be responsible for all marketing and sales of Zingo in their territory. The
Under the terms of the agreement, Merck will provide up-front and research support funding to the CACS as well as milestone and royalty payments upon market approval. The
Watson is seeking marketing approval of silodosin from the FDA for the treatment of the signs and symptoms associated with benign prostatic hyperplasia (BPH), or enlarged prostate. Watson
Early data from the ongoing Phase II clinical trial for first-line treatment of colorectal cancer patients confirmed that 43% of evaluable patients have significant tumor shrinkage. In addition,
The primary study endpoints were reduction of Post Prandial Blood Sugar (PPBS) by 20mg/dl from the baseline value and reduction of glycosylated hemoglobin (HbA1c) by 0.7% from the